S

SNY

Sanofi FR

47.89

+0.16+0.34%
After Hours: 48.15  +0.26  +0.54%19:33 04/02 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE47.48/47.73
TODAY RANGE47.29-47.96
VOL1.52M
MARKET CAP115.66B
52 WEEK RANGE43.32-53.42
AVG VOL (3M)4.21M
% TURNOVER0.06%
TURNOVER--
P/E (TTM)12.80
% RANGE1.39%
EPS(TTM)3.741
P/E(FORWARD)18.14
P/B1.381
BVPS34.69
DIVIDEND2.195
P/S2.109
BETA--
DIV YIELD4.58%
FREE FLOAT MKT CAP115.65B
SHARES OUTSTANDING2.42B
NEXT EARNINGS01/28-02/02
FREE FLOAT2.42B
LOT SIZE1
EX-DATE05/09/2025
Same Industry
Name/Symbol
Change%
Price

SNY

--

麥克森

MCK

+1.37%
884.28

BIIB

--

A

Amgen Inc

AMGN

-1.51%
347.94

CELG-RT

--

沙爾製藥

SHPG

0.00%
179.20

新基醫藥

CELG

0.00%
108.24

L

Lilly Eli & Co

LLY

-1.98%
935.58

T

Therapeuticsmd Inc

TXMD

0.00%
2.000

強生

JNJ

-0.44%
243.04

A

Abbvie Inc

ABBV

-2.86%
208.84

Z

Zoetis Inc

ZTS

+0.55%
117.94

吉利德科學

GILD

-0.42%
139.71

諾和諾德

NVO

+1.37%
36.98

B

Bristol-Myers Squibb Co

BMY

-2.46%
59.60

亞力兄製藥

ALXN

+1.70%
182.50

輝瑞製藥

PFE

-0.81%
28.32

GCVRZ

--

N

Novartis

NVS

-0.68%
154.03

RDY

--

G

GSK PLC

GSK

+1.25%
56.69

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.